Collusion Coverup: Department Of Justice Intervenes In Pfizer Fraud Case, In A Corrupt Attempt To Shut The Case Down

Collusion Coverup: Department Of Justice Intervenes In Pfizer Fraud Case, In A Corrupt Attempt To Shut The Case Down

NaturalNews.com | Lance D Johnson

- The United States Department of Justice (DOJ) is attempting to shut down the Pfizer fraud case scheduled for April 17.

- The lawsuit alleges that Pfizer-BioNTech violated the False Claims Act during their clinical trials and knowingly delivered a defective product to the world.

- Former employee Brook Jackson, who worked at Ventavia Research Group (a company that conducted some of Pfizer's COVID-19 vaccine clinical trials), is suing Pfizer, her former employer Ventavia, and another Pfizer contractor, ICON plc.

- The DOJ asked the court to dismiss the lawsuit, claiming it would be inconsistent with their public health policy.

- The DOJ's motion to dismiss cites a flimsy hypothesis authored by the FDA, which supports the faulty vaccines and contradicts Jackson's claims of fraud and negligence.


The United States Department of Justice (DOJ) just made a brazen attempt to shut down the Pfizer fraud case that is scheduled for April 17 before the U.S. District Court for the Eastern District of Texas Beaumont Division. The lawsuit alleges that Pfizer-BioNTech violated the False Claims Act during their clinical trials and knowingly delivered a defective product to the world.

The lawsuit was filed by Brook Jackson, a whistleblower and former employee of the Ventavia Research Group. Ventavia conducted some of the clinical trials for Pfizer’s mRNA covid-19 vaccines. Jackson provides evidence that Pfizer committed fraud to get a vaccine contract with the federal government. This fraud led to the FDA’s approval of an ineffective and unsafe vaccine that caused numerous injuries and deaths, while providing no substantial immunity to the alleged causative agent. According to the claim, Pfizer-BioNTech violated the protocols for their COVID-19 vaccine clinical trial at three study sites in Texas. Jackson not only sued Pfizer, but also her former employer Ventavia and another Pfizer contractor, ICON plc.

“This fraud has undoubtedly cost American taxpayers billions of dollars and has led to an untold number of injuries from the COVID-19 countermeasure, including permanent disability and death among my fellow citizens,” Jackson said.

At a March 8 presentation of the Vaccine Safety Research Foundation, one of the lawyers representing Jackson spoke about the extent of the fraud. "Any and every form of fraud they [Pfizer] could commit, they did," said Robert Barnes. "[Jackson] discovered it, uncovered it and went through the appropriate internal review protocols and assumed that people would correct the defects,” Barnes said. “And instead of that occurring, she was summarily fired."

DOJ asks court to dismiss lawsuit against Pfizer

The DOJ already revealed their partiality in this case when they asked the court to dismiss the lawsuit. “The United States should not be required to expend resources on a case that is inconsistent with its public health policy,” the DOJ said in its motion to dismiss.

If the DOJ’s “public health policy” includes shutting down investigation and covering up evidence of Pfizer’s fraud, then the government agency itself is suspect in a much grander investigation of fraud and medical malfeasance.

The very agencies that are meant to hold corporations accountable cannot willfully act in the best interest of those corporations and refuse to hear the evidence of why these vaccines were a failure from the start. With this arrogant move, the DOJ seeks to dismiss well-cited claims of fraud. With this suspicious act, the DOJ seeks to shut down evidence of injustices that were waged against the people of the United States. This is corruption at its finest, and the fight must go on.

DOJ peddles vaccine propaganda, completely ignoring evidence of fraud

The False Claims Act “requires the United States to notify the court whether it will intervene in the qui tam action or decline to take over the action,” following “a period of investigation.” A qui tam action refers to any legal case where a private citizen initiates legal action on behalf of a state. In qui tam cases, the government must choose whether to intervene. They can either file a motion to dismiss or try to settle the case on behalf of the citizen who originally filed the claim. The DOJ decided to double down on their support for Pfizer’s fraud and willful negligence. Instead of standing by the whistleblower, the DOJ decided to come against her.

To justify their support for Pfizer, the DOJ argued that the discovery process and ongoing legal proceedings “will impose a significant burden on FDA, HHS [U.S. Department of Health and Human Services] and DOJ.”

The DOJ's motion to dismiss cites a flimsy hypothesis authored by the very agency (the FDA) that was used by Pfizer to push the faulty vaccines. The DOJ cites a Jan. 5, 2024, JAMA editorial authored by FDA Commissioner Robert Califf and the FDA’s Center for Biologics Evaluation and Research Director Peter Marks, claiming that: "Contrary to a wealth of misinformation available on social media and the internet, data from various studies indicate that since the beginning of the COVID-19 pandemic tens of millions of lives were saved by vaccination."

This hyperbolic statement about the "savior" COVID-19 vaccines makes Jackson's lawsuit even more important. Further discovery into this matter continues to uncover a trail of corruption, fraud and propaganda within the government agencies. Not only did the Biden Administration unlawfully mandate a product in violation of the U.S. Constitution and the Nuremberg Code, but they also falsely advertised a harmful intervention, while willfully and negligently pushing it out into the population, with deleterious effects.


Sources:

ChildrensHealthDefense.org

Justice.gov

Sashalatypova.substack.com

ChildrensHealthDefense.org [PDF]

Law.Cornell.edu

Ori.HHS.gov

Original Article: https://www.naturalnews.com/2024-03-22-department-of-justice-intervenes-pfizer-fraud-case.html